Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks.
作者信息
Lee Jisoo, Chin Susie, Kim Sang Gyune, Kim Young Seok, Yoo Jeong-Ju
机构信息
Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Pathology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
出版信息
J Korean Med Sci. 2025 Sep 8;40(35):e271. doi: 10.3346/jkms.2025.40.e271.
Abstract
摘要
相似文献
1
Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks.
J Korean Med Sci. 2025 Sep 8;40(35):e271. doi: 10.3346/jkms.2025.40.e271.
2
Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.
Medicine (Baltimore). 2017 Nov;96(47):e8905. doi: 10.1097/MD.0000000000008905.
3
The hepatotoxicity assessment of micro/nanoplastics: A preliminary study to apply the adverse outcome pathways.
Sci Total Environ. 2023 Dec 1;902:165659. doi: 10.1016/j.scitotenv.2023.165659. Epub 2023 Jul 29.
4
Update on the adverse effects of microcystins on the liver.
Environ Res. 2021 Apr;195:110890. doi: 10.1016/j.envres.2021.110890. Epub 2021 Feb 19.
5
The protective effect of Schisandra lignans on the hepatotoxicity induced by the metabolic activation of dictamnine.
J Ethnopharmacol. 2025 Aug 29;352:120170. doi: 10.1016/j.jep.2025.120170. Epub 2025 Jun 18.
6
Risk prediction of hepatotoxicity in paracetamol poisoning.
Clin Toxicol (Phila). 2017 Sep;55(8):879-892. doi: 10.1080/15563650.2017.1317349. Epub 2017 Apr 27.
7
Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.
J Korean Med Sci. 2022 Aug 22;37(33):e255. doi: 10.3346/jkms.2022.37.e255.
8
Hesperidin Reduces Hepatic Injury Induced by Doxorubicin in Rat Model Through Its Antioxidative and Anti-Inflammatory Effects, Focusing on SIRT-1/NRF-2 Pathways.
J Biochem Mol Toxicol. 2025 Sep;39(9):e70465. doi: 10.1002/jbt.70465.
9
Targeted inhibition of STING-TBK1 axis alleviates the hepatotoxicity of tripterygium glycosides.
Hum Exp Toxicol. 2025 Jan-Dec;44:9603271251369053. doi: 10.1177/09603271251369053. Epub 2025 Aug 13.
10
Real-world pharmacovigilance assessment of hepatotoxicity risk with HER2-Targeted drugs using FAERS database analysis.
Sci Rep. 2025 Aug 6;15(1):28790. doi: 10.1038/s41598-025-14064-2.
本文引用的文献
1
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.
Drug Saf. 2024 Jul;47(7):673-686. doi: 10.1007/s40264-024-01418-4. Epub 2024 Mar 21.
2
Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.
J Korean Med Sci. 2022 Aug 22;37(33):e255. doi: 10.3346/jkms.2022.37.e255.
3
EASL Clinical Practice Guidelines: Drug-induced liver injury.
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
4
Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.
Medicine (Baltimore). 2017 Nov;96(47):e8905. doi: 10.1097/MD.0000000000008905.
Zotero 插件